FDA Adverse Event Malfunction Summary report: N

CAPIOX®FX

MDR report key: 25148881 · Received May 12, 2026

Report

Report Number
9681834-2026-00094
Event Type
Malfunction
Date Received
May 12, 2026
Report Date
May 12, 2026
Manufacturer
TERUMO CORPORATION, ASHITAKA
Product Code
DTZ
PMA / PMN Number
K071572
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

D4: UDI: N/A AS THIS PRODUCT CODE IS NOT EXPORTED TO THE US MARKET. D6A: IMPLANTED DATE: DEVICE WAS NOT IMPLANTED. D6B: EXPLANTED DATE: DEVICE WAS NOT EXPLANTED. E3: OCCUPATION: CLINICAL ENGINEER G4: 510(K) NO: K1300280 H4: DEVICE MANUFACTURE DATE: UNKNOWN DUE TO UNKNOWN LOT NUMBER. SINCE THE ACTUAL DEVICE WAS NOT AVAILABLE AND THE LOT WAS UNKNOWN, THE INVESTIGATION OF THE MANUFACTURING RECORDS COULD NOT BE PERFORMED. SINCE THE LOT NUMBER OF THE ACTUAL DEVICE WAS UNKNOWN, IT WAS NOT POSSIBLE TO INVESTIGATE THE MANUFACTURING HISTORY OR SHIPPING INSPECTION RECORD. SINCE THE LOT INFORMATION WAS UNKNOWN, IT WAS NOT POSSIBLE TO CONFIRM THE MANUFACTURING DATE OR EXPIRATION DATE. AS A RESULT OF INVESTIGATING THE COMPLAINT FILE, NO SIMILAR REPORT WAS FOUND REGARDING THE INVOLVED PRODUCT CODE FOR THE PAST THREE YEARS FROM OTHER FACILITIES. RELEVANT INSTRUCTIONS FOR USE (IFU) REFERENCE: "DO NOT REDUCE HEPARIN DURING CIRCULATION. OTHERWISE, BLOOD CLOTTING MIGHT OCCUR." "ADEQUATE HEPARINIZATION OF THE BLOOD IS REQUIRED TO PREVENT IT FROM CLOTTING IN THE SYSTEM." TERUMO MEDICAL CORPORATION (TMC) (IMPORTER) REGISTRATION NO. 2243441 IS SUBMITTING THIS REPORT ON BEHALF OF ASHITAKA FACTORY OF TERUMO CORPORATION (MANUFACTURER) REGISTRATION NO. 9681834.

Description of Event or Problem · 0

TERUMO RECEIVED THE FOLLOWING REPORTED INFORMATION: THE OXYGENATOR HAD AN INCREASE IN INLET PRESSURE. THE DEVICE WAS NOT REPLACED AND WEANED. THERE WAS NO PATIENT HARM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
525999 CAPIOX®FX OXYGENATOR, CARDIOPULMONARY BYPASS DTZ TERUMO CORPORATION, ASHITAKA CX-FX05W

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown